Schonfeld Strategic Advisors’s Cullinan Oncology CGEM Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,638	Closed	-$172K	–	2283
2025 Q4	$172K	Buy	+16,638	New	+$150K	﹤0.01%	1743
2024 Q2	–	Sell	-60,074	Closed	-$1.02M	–	2201
2024 Q1	$1.02M	Sell	60,074 -80,926	-57%	-$1.25M	0.01%	1216
2023 Q4	$1.44M	Buy	141,000 +19,200	+16%	+$170K	0.01%	918
2023 Q3	$1.1M	Buy	121,800 +16,700	+16%	+$174K	0.01%	990
2023 Q2	$1.13M	Buy	105,100 +70,700	+206%	+$751K	0.01%	932
2023 Q1	$352K	Buy	34,400 +400	+1%	+$4.41K	﹤0.01%	1305
2022 Q4	$359K	Buy	+34,000	New	+$413K	﹤0.01%	1711
2021 Q4	–	Sell	-35,858	Closed	-$809K	–	2185
2021 Q3	$809K	Buy	+35,858	New	+$959K	0.01%	1044
2021 Q2	–	Sell	-48,373	Closed	-$2.02M	–	1983
2021 Q1	$2.02M	Buy	+48,373	New	+$1.96M	0.03%	657

Other funds holding CGEM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return